By Cara Salvatore ( May 6, 2015, 3:02 PM EDT) -- A New York federal judge has dismissed a shareholder class action against Dutch biotech company Prosensa Holding NV over a stock drop following a clinical-trial failure for its crown-jewel drug, saying Tuesday the plaintiffs didn't plead that executives omitted necessary information....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.